Peregrine Capital Management’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.8M | Buy |
1,012,100
+101,592
| +11% | +$582K | 0.17% | 161 |
|
|
2025
Q1 | $7.43M | Buy |
910,508
+29,991
| +3% | +$245K | 0.25% | 114 |
|
|
2024
Q4 | $8.29M | Buy |
880,517
+135,716
| +18% | +$1.28M | 0.25% | 110 |
|
|
2024
Q3 | $7.95M | Sell |
744,801
-68,137
| -8% | -$728K | 0.24% | 109 |
|
|
2024
Q2 | $8.06M | Buy |
812,938
+79,389
| +11% | +$788K | 0.24% | 121 |
|
|
2024
Q1 | $8.64M | Buy |
733,549
+128,201
| +21% | +$1.51M | 0.25% | 112 |
|
|
2023
Q4 | $8.59M | Sell |
605,348
-123,337
| -17% | -$1.75M | 0.26% | 114 |
|
|
2023
Q3 | $8.86M | Buy |
728,685
+19,014
| +3% | +$231K | 0.26% | 134 |
|
|
2023
Q2 | $8.91M | Sell |
709,671
-86,893
| -11% | -$1.09M | 0.24% | 164 |
|
|
2023
Q1 | $8.83M | Buy |
796,564
+92,697
| +13% | +$1.03M | 0.25% | 168 |
|
|
2022
Q4 | $8.59M | Sell |
703,867
-108,494
| -13% | -$1.32M | 0.27% | 173 |
|
|
2022
Q3 | $8.48M | Buy |
812,361
+31,957
| +4% | +$334K | 0.27% | 169 |
|
|
2022
Q2 | $8.38M | Sell |
780,404
-46,916
| -6% | -$504K | 0.25% | 175 |
|
|
2022
Q1 | $7.84M | Sell |
827,320
-47,451
| -5% | -$449K | 0.19% | 218 |
|
|
2021
Q4 | $10.1M | Buy |
874,771
+164,919
| +23% | +$1.9M | 0.2% | 199 |
|
|
2021
Q3 | $6.78M | Sell |
709,852
-10,734
| -1% | -$103K | 0.14% | 241 |
|
|
2021
Q2 | $6.95M | Buy |
720,586
+30,799
| +4% | +$297K | 0.12% | 252 |
|
|
2021
Q1 | $6.82M | Buy |
689,787
+18,969
| +3% | +$187K | 0.13% | 252 |
|
|
2020
Q4 | $15.5M | Sell |
670,818
-312,479
| -32% | -$7.22M | 0.29% | 149 |
|
|
2020
Q3 | $13.9M | Sell |
983,297
-3,119
| -0.3% | -$44K | 0.37% | 104 |
|
|
2020
Q2 | $14.9M | Sell |
986,416
-273,691
| -22% | -$4.13M | 0.42% | 97 |
|
|
2020
Q1 | $11.6M | Buy |
1,260,107
+4,527
| +0.4% | +$41.8K | 0.42% | 99 |
|
|
2019
Q4 | $12.2M | Buy |
+1,255,580
| New | +$12.2M | 0.31% | 130 |
|